Abeona Therapeutics Statistics
Total Valuation
ABEO has a market cap or net worth of $367.81 million. The enterprise value is $169.95 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, before market open.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ABEO has 51.16 million shares outstanding. The number of shares has increased by 92.58% in one year.
Current Share Class | 51.16M |
Shares Outstanding | 51.16M |
Shares Change (YoY) | +92.58% |
Shares Change (QoQ) | +33.87% |
Owned by Insiders (%) | 5.83% |
Owned by Institutions (%) | 55.43% |
Float | 39.30M |
Valuation Ratios
The trailing PE ratio is 7.26 and the forward PE ratio is 92.18.
PE Ratio | 7.26 |
Forward PE | 92.18 |
PS Ratio | 928.48 |
Forward PS | 7.31 |
PB Ratio | 2.27 |
P/TBV Ratio | 2.27 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 2.97 |
EV / Sales | 424.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.73, with a Debt / Equity ratio of 0.15.
Current Ratio | 6.73 |
Quick Ratio | 6.58 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -18.01 |
Financial Efficiency
Return on equity (ROE) is 48.34% and return on invested capital (ROIC) is -32.80%.
Return on Equity (ROE) | 48.34% |
Return on Assets (ROA) | -24.50% |
Return on Invested Capital (ROIC) | -32.80% |
Return on Capital Employed (ROCE) | -35.21% |
Revenue Per Employee | $2,941 |
Profits Per Employee | $420,897 |
Employee Count | 136 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ABEO has paid $15.51 million in taxes.
Income Tax | 15.51M |
Effective Tax Rate | 21.32% |
Stock Price Statistics
The stock price has increased by +46.67% in the last 52 weeks. The beta is 1.54, so ABEO's price volatility has been higher than the market average.
Beta (5Y) | 1.54 |
52-Week Price Change | +46.67% |
50-Day Moving Average | 6.26 |
200-Day Moving Average | 5.80 |
Relative Strength Index (RSI) | 70.24 |
Average Volume (20 Days) | 623,494 |
Short Selling Information
The latest short interest is 8.42 million, so 16.45% of the outstanding shares have been sold short.
Short Interest | 8.42M |
Short Previous Month | 8.48M |
Short % of Shares Out | 16.45% |
Short % of Float | 21.42% |
Short Ratio (days to cover) | 11.55 |
Income Statement
In the last 12 months, ABEO had revenue of $400,000 and earned $57.24 million in profits. Earnings per share was $0.99.
Revenue | 400,000 |
Gross Profit | -34.06M |
Operating Income | -74.54M |
Pretax Income | -76.66M |
Net Income | 57.24M |
EBITDA | -72.43M |
EBIT | -74.54M |
Earnings Per Share (EPS) | $0.99 |
Full Income Statement Balance Sheet
The company has $225.52 million in cash and $24.08 million in debt, giving a net cash position of $201.44 million or $3.94 per share.
Cash & Cash Equivalents | 225.52M |
Total Debt | 24.08M |
Net Cash | 201.44M |
Net Cash Per Share | $3.94 |
Equity (Book Value) | 163.58M |
Book Value Per Share | 3.19 |
Working Capital | 197.75M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$65.98 million and capital expenditures -$5.31 million, giving a free cash flow of -$71.29 million.
Operating Cash Flow | -65.98M |
Capital Expenditures | -5.31M |
Free Cash Flow | -71.29M |
FCF Per Share | -$1.39 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -18,634.00% |
Pretax Margin | 18,188.50% |
Profit Margin | 14,310.50% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -92.58% |
Shareholder Yield | -92.58% |
Earnings Yield | 15.41% |
FCF Yield | -19.20% |
Dividend Details Analyst Forecast
The average price target for ABEO is $18.17, which is 152.71% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.17 |
Price Target Difference | 152.71% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside | |
Stock Splits
The last stock split was on July 5, 2022. It was a reverse split with a ratio of 1:25.
Last Split Date | Jul 5, 2022 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |